Stock Screener App

무료 -

설치하다

2.01

0.25% -0.005

Aclarion Inc (ACON)

개요 뉴스 가격 이력 Financials 토론 예측

Aclarion Inc 주식(ACON)의 최신 뉴스

Aclarion, Inc. Revenue Breakdown – BOATS:ACON - TradingView

Aclarion Inc (ACON) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Aclarion Inc (ACON) Institutional Confidence - TradingKey

Aclarion Inc (ACON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Aclarion Inc (ACON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Aclarion Inc (ACON) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

ACON|Aclarion Inc|Price:2.420|Chg%:-0.030 - TradingKey

Aclarion Market Sentiment - Benzinga España

TradingKey - TradingKey

Aclarion, Inc. Revenue Breakdown – TRADEGATE:IT20 - TradingView

Aclarion, Inc. Revenue Breakdown – NASDAQ:ACONW - TradingView

Aclarion Inc (ACON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice - Ortho Spine News

Aclarion Nociscan Case Reports 95% Relief Without Classic MRI Signs - Stock Titan

Aclarion, Inc. Warrant 2022- on Aclarion Financial Disclosures & SEC Filings - TradingView

Return on equity % of Aclarion, Inc. – TRADEGATE:IT20 - TradingView

Aclarion Inc. (ACON) Slides 2.6% as Support Levels Face Renewed PressureDouble Bottom - dars.gov.et

Aclarion Inc. (ACON) Faces Resistance After 5.41% Decline – Key Levels in FocusRatio Spread Trade - dars.gov.et

Price to sales forward of Aclarion, Inc. – NASDAQ:ACONW - TradingView

Number of shareholders of Aclarion, Inc. – NASDAQ:ACONW - TradingView

Price to earnings forward of Aclarion, Inc. – BOATS:ACONW - TradingView

ACON Q1 2026 Earnings: EPS Surprises to the Upside Despite Stock DeclinePerformance Review - DonanımHaber

Aclarion Inc. (ACON) Consolidates Near $3.02 as Micro-Cap Healthcare Stock Eyes Resistance at $3.17Bullish Sentiment - dars.gov.et

Aclarion Announces Texas Spine Care Center as New CLARITY Site - marketscreener.com

Aclarion adds Texas Spine Care Center to CLARITY trial By Investing.com - Investing.com Nigeria

Aclarion adds Texas Spine Care Center to CLARITY trial - Investing.com

Aclarion expands CLARITY trial with Texas spine center - Stock Titan

Aclarion Inc. Warrant (ACONW) Slips 6.85%, Hovers at Critical $0.02 LevelBreakaway Gap - dars.gov.et

Aclarion Inc. Warrant (ACONW) Slips Again: Warrants Trade Near $0.02 Amid Thin VolumeShort Term Trading Ideas - dars.gov.et

ACONW Extends Decline: A Closer Look at Aclarion Inc. WarrantsAnalyst Upgrade Stocks - dars.gov.et

Aclarion Inc. Q1 2026 Earnings: EPS Surprise Drives Stock Rally Amid Revenue AbsenceEarnings Turnaround - dars.gov.et

ACON Q1 2026 Earnings: EPS Surpasses Analyst Estimates Despite Lack of Revenue DisclosureFull Year Guidance - dars.gov.et

Enterprise value to EBIT forward of Aclarion, Inc. – NASDAQ:ACON - TradingView

Price to book forward of Aclarion, Inc. – NASDAQ:ACON - TradingView

A412BH Forecast — Price Target — Prediction for 2027 - TradingView

Aclarion, Inc. Actuals & Estimates (NASDAQ:ACON) - TradingView

ACON Forecast — Price Target — Prediction for 2027 - TradingView

Aclarion Inc (ACONW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aclarion Inc. (ACON) Q1 2026 Earnings: Narrower-than-expected Loss Drives EPS Beat, Yet Shares Slide 4.9%EPS Growth Report - DonanımHaber

Aclarion Inc. (ACON) Q1 2026 Earnings: EPS Surpasses Estimates with 15% Beat Despite No RevenueGAAP Earnings Report - dars.gov.et

Aclarion Inc (ACONW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

ACON Q1 2026 Earnings: EPS Surprises Positively Despite Absence of RevenueAdjusted Earnings Analysis - Bölüm Sonu Canavarı

Aclarion Inc. Warrant (ACONW) Surges 38% From Penny Levels – But Caution WarrantedBPI Bull Correction - Město Břeclav

Aclarion Inc. Holds Steady Near Key Resistance Level (ACON)RTH Profile - dars.gov.et

Aclarion (ACON) upgraded to buy: Here's why - MSN

Aclarion Inc (ACONW) Valuation: PE, PB & Fair Value Analysis - TradingKey

Aclarion Inc (ACONW) Institutional Confidence - TradingKey

Aclarion Inc (ACONW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Aclarion Inc (ACONW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Aclarion Inc (ACONW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Aclarion Inc (ACONW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Aclarion Inc (ACONW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Aclarion Inc (ACON) Valuation: PE, PB & Fair Value Analysis - TradingKey

Aclarion Inc (ACON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aclarion Inc (ACON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Aclarion board rejects Echo Lake’s $4 per share takeover bid By Investing.com - Investing.com Nigeria

Aclarion Inc. (ACON) Q1 2026 Earnings: EPS Surpasses Estimates Despite Ongoing Revenue AbsenceEarnings Season Outlook - newsline.com

Aclarion Inc. (ACON) Slides Amid Light Trading, Support at $2.96 in FocusTRIN Signal - newsline.com

PRVA

$23.79

1.29%

DOCS

$20.98

3.01%

PINC

$50.09

0.08%

WAY

$21.75

11.66%

HNGE

$74.58

0.48%

TXG

$47.71

1.90%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기 | MarketWatch에서 열기 | EDGAR에서 열기 | 로이터에서 공개